Decatur Memorial Hospital operator Illinois Health and Science is acquiring, for an undisclosed price, radiopharmaceutical manufacturer IBA Molecular, according to IBAM.
IBA Molecular North America will continue to operate as an independent company headquartered in Dulles, Virginia.
The collaboration will provide a network of accessible supply locations for all medical-use radiopharmaceuticals, according the company.
The move boosts Illinois Health and Science’s development of a new, high-capacity radiopharmaceutical production facility in Indianapolis, through its company Zevacor Molecular.
Illinois Health and Science is the parent company of Decatur Memorial Hospital, a regional not-for-profit hospital with over $900 million in revenue.